For over 35 years, expanded PolyTetraFluoroEthylene (ePTFE) has been a mainstay of the cardiovascular device industry.

This durable biocompatible material has been approved for use in products ranging from vascular grafts to Endovascular AAA devices, having withstood the rigorous demands of clinicians and regulatory bodies worldwide.

BD Peripheral Intervention OEM Products offers implantable ePTFE products and custom encapsulation services that allow medi­cal device manufacturers to incorporate ePTFE into their own devices. OEMs benefit from the company’s four decades of trusted, industry-proven expertise.

The physical properties of ePTFE make it highly suitable for use in implantable vascular devices. It can allow devices to withstand flexion created by pressure pulses by adapting to the natural action of blood vessels. The material is also exceptionally durable and resistant to wear inside the body, making it viable for safe stent deployment. In addition, ePFTE’s permeability enables outgassing while preventing leakage. It is temperature stable, chemically inert and hydrophobic. Further, its microporous nature encourages tissue ingrowth, which can be beneficial for anchoring implanted devices.

ePTFE is available in a wide variety of tubular diameters, lengths, widths, and wall thicknesses. It is used by medical device manufacturers in applications such as:

• Stent Coverings

• Orthopedic Implant Components

• CABG Devices

• Septal Defect Devices

• LVAD Cannulae Components

• Vascular Grafts

For 40 years, BD Peripheral Intervention OEM Products has offered innovative solutions to medical device manufacturers that combine best-in-class technologies with a proven commitment to quality. The company offers custom ePTFE encapsulation services to cardiovascular device manufacturers, leveraging the capabilities used to manufacture C.R. Bard’s own industry-leading stent graft products.

Choosing an ePTFE provider like BD Peripheral Intervention OEM that has ISO Certified facilities; approved and well- maintained quality systems; control of critical IP; long-term access to raw materials; and a documented history of clinical and regulatory success helps ensure a streamlined process and a finished device that meets expectations.

Read our full ePTFE white paper here.